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 Summary  
Gene expression depends on binding of transcriptional regulators to gene promoters, a process controlled by signalling pathways. The transcriptional repressor BCL-6 
downregulates genes involved in cell cycle progression and becomes inactivated following phosphorylation by the Rac1 GTPase activated protein kinase PAK1. 
Interestingly, the DNA motifs recognized by BCL-6 and STAT5 are similar. Because STAT5 stimulation in epithelial cells can also be triggered by Rac1 signalling, we 
asked whether both factors have opposing roles in transcriptional regulation and whether Rac1 signalling may coordinate a transcription factor switch. We used 
chromatin immunoprecipitation to show that active Rac1 promotes release of the repressor BCL-6 while increasing binding of STAT5A to a BCL-6-regulated reporter 
gene. We further show in colorectal cell lines that the endogenous activation status of the Rac1/PAK1 pathway correlated with the phosphorylation status of BCL-6 
and STAT5A. Three cellular genes (cyclin D2, p15INK4B, SUMO1) were identified to be inversely regulated by BCL-6 and STAT5A and responded to Rac1 signalling with 
increased expression and corresponding changes in promoter occupancy. Together, our data show that Rac1 signalling controls a group of target genes that are 
repressed by BCL-6 and activated by STAT5A, providing novel insights into the modulation of gene transcription by GTPase signalling. 
Previous work: Rac1 Signaling Modulates BCL-6-Mediated Repression of Gene Transcription 
Conclusion & Perspectives:  
• We identified a novel pathway through which Rac1 signalling can modulate 
the expression of a selected group of target genes. 
• The next step will be the genome-wide identification of these genes to plot a 
profile of the impact of this pathway in the regulation of the cells 
transcriptome.   
New Data:  The STAT5/BCL-6 transcriptional switch downstream of Rac1  
A novel Rac1/PAK1/BCL6/STAT5 pathway modulates the expression of 
cell-cycle-associated genes in colorectal cancer cells 
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(A) DLD-1 cells were transfected with Myc-Rac1-Q61L or control 
vector and analyzed by Western blot for the subcellular distribution 
of STAT5 between a soluble (S) and a chromatin-bound non-soluble 
(NS) fraction (detection of α-tubulin and histone 2B served as 
controls). (B) Subcellular localisation of STAT5 determined by 
confocal fluorescence microscopy in DLD-1 cells co-transfected with 
DsRed-Rac1-Q61L and GFP-STAT5A. Shown is the overlay image of 
the DAPI (blue), GFP and DsRed channels. Note the nuclear STAT5 
signal in Rac1-expressing red cells. In addition, DAPI and GFP signal 
intensities were measured along the indicated regions of interest 
(ROI, white lines). Note that nuclear GFP-STAT5 signal clearly 
increases when cells co-express active Rac1 (red cells, ROI 2 vs. green 
cells, ROI 1).  
Rac1 promotes nuclear translocation and 
chromatin binding of STAT5 
Why can’t active PAK1  fully replace Rac1 in 
stimulating the BCL-6 reporter?  
? 
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STAT5 
DLD-1 cells were co-
transfected with 5x BCL-6 
reporter and the 
indicated expression 
vectors or siRNAs. Cells 
were lysed and luciferase 
activity was measured 
(*P< 0.05). The Western 
blot below the graph 
shows the levels of trans-
fected GFP-tagged 
proteins. Detection of 
endogenous α-tubulin 
served as loading control.  
Interesting...! 
(A) DLD-1 cells were co-transfected with the BCL-6 reporter 
and the indicated constructs. Note that STAT5 activates the 
BCL-6 luciferase reporter and, when combined with PAK1, 
reaches the stimulation levels normally induced by active 
Rac1, *P<0.05 and #P>0.05. (B) Chromatin immuno-
precipitation (ChIP) of the BCL-6 reporter promoter with 
anti (α)-BCL-6, α-STAT5 or a non-specific antibody (NS IgG) 
from DLD-1 cells transfected as indicated. Shown is a 
representative PCR of the precipitated promoter fragment 
quantities, together with the plot of quantitative PCR 
analysis of 3 independent experiments, *P<0.05.  
Rac1 signalling switches promoter 
occupancy from BCL-6 to STAT5 
A 
B 
Equivalent lysate quantities of DLD-1, SW480 and HT29 
colorectal cells were separated by gel electrophoresis and 
analysed by Western blot using the indicated antibodies to 
compare protein levels. The active Rac1 fraction was 
obtained by CRIB-pull down assays. 
Correlation of Rac1 signalling and activation 
of PAK1, BCL-6 or STAT5 in CRC cell lines 
Identification of endogenous genes inversely regulated 
by BCL-6 and STAT5 
(A) DLD-1 and HT29 cells were transfected with either BCL-6 or STAT5-
specific siRNAs. Shown is a heat map display of the gene expression 
analysis of a cell-cycle PCR array probed with RNA samples obtained from 
these cells. Among the 84 genes on the array, three were identified to be 
inversely regulated by BCL-6 and STAT5 (see white boxes). (B) Schematic 
representation of the promoter regions of the three selected genes, 
showing the predicted binding motifs with the best scores, equivalent for 
both factors.  
Shown is the analysis of the SUMO1 gene in all three colorectal cell lines 
transfected as indicated (equivalent results were obtained for the other 2 
genes – see bottom insert). Top panels show  ChIP analysis of promoter 
occupancy by BCL-6 (black columns) or STAT5 (white columns) and middle 
panels the respective gene expression levels, *P<0.05. Bottom panels show 
Western blot analysis of tranfected protein levels as well as the 
phosphorylation status of endogenous STAT5. Note that in SW480 depletion 
PAK1 siRNA or expression of KD PAK1 has no effect on promoter-bound BCL-
6 whereas restoration of PAK1 expression leads to loss of BCL-6 from the 
promoter and an increase in gene expression. In the other two cell lines, 
inhibition of Rac1 or PAK1 are clearly correlated with more BCL-6 bound and 
less gene expression while activation of Rac1 or PAK1 promoted STAT5 
binding and increased transcription. 
Rac1 signalling controls target gene expression by 
switching promoter occupancy with either BCL-6 or STAT5 
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STAT5 and BCL-6 regulation of the CCND2, CDKN2B and 
SUMO1 genes 
A 
B 
(A) CCND2, CDKN2B and SUMO1 gene promoter occupancy by BCL-6 and 
STAT5 was determined by ChIP in the three indicated cell lines. Shown are a 
representative PCR of the precipitated promoter fragments and a plot of 
the quantitative analysis of 3 independent experiments, *P<0.05. A 
genomic fragment from the MUTYH gene was amplified to confirm the 
specificity of the precipitated target gene promoters. Note that BCL-6 binds 
predominantly in the PAK1-lacking SW480 cells and whereas a clear switch 
to STAT5 occurs in DLD-1 and HT29 cells with active Rac1/PAK1 signalling. 
(B) Expression analysis data for the selected genes in the 3 cell lines. Left 
panel shows representative RT-PCRs while quantitative PCR data is plotted 
in the right graph. RNA polymerase II (POL2) and phosphoglycerate kinase 
(PGK1) were amplified as control housekeeping genes. 
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Ab array screening for new 
Rac1 signalling partners 
BCL-6 !? 
DLD-1 colorectal cells were co-transfected 
with GFP-Rac1 L61 and cells lysates used to 
probe an array of immobilized antibodies 
against  400 proteins involved in signal 
transduction. Among several positive signals, 
including many known Rac1 signalling 
partners, was the B-cell lymphoma-associated 
transcriptional repressor, i.e., BCL-6... 
Active Rac1 affects sub-nuclear location and chromatin-binding of BCL-6 and 
releases its transcriptional repression 
(A) DLD-1 colorectal cells were co-transfected with GFP-BCL-6 and either DsRed vector or DsRed-Rac1-L61 as indicated. 
Cells were fixed after 24 h, nuclei counterstained with DAPI and fluorescent signals recorded by confocal microscopy. 
Note that BCL-6 loses its typical localization to nuclear dots. (B) DLD-1 cells were co-transfected with GFP-BCL-6 and 
the indicated Myc-tagged vectors and lysed after 24 h so that a soluble (S) and a non-soluble (NS), chromatin-bound 
fraction was obtained. Shown is the Western blot analysis of these fractions. Note the BCL-6 becomes predominantly 
soluble in a non-chromatin bound cell fraction upon co-expression of active Rac1. (C) DLD-1 cells were transfected 
with a transcriptional luciferase reporter vector under the control of five consensus BCL-6 binding motifs (see below). 
Cells were co-transfected with the indicated expression vectors or mock-transfected and treated with the Rac1 
inhibitor NSC23766. Note that expression of active Rac1 releases BCL-6 repression, increasing Luciferase expression. 
(A) DLD-1 cells were transfected with the indicated siRNAs and with the 5xBCL-6 luciferase reporter in the presence 
or absence of Rac1-L61. When indicated, cells were incubated with 10 mM PAK inhibitor IPA-3. Note that 
interference with PAK1 by depletion or inhibitor treatment blocks Rac1-mediated activation of BCL-6. (B) BCL-6 and 
PAK1 co-immunoprecipitate. DLD-1 cells were co transfected with Myc-PAK1 and either GFP control vector or GFP-
BCL-6 or GFP-Rac1-L61 as positive control. Cell extracts were incubated with anti-GFP antibodies and analyzed for co-
precipitated Myc-PAK1. (C) PAK1 phosphorylates BCL-6. GFP control or GFP-BCL-6 were transfected into DLD-1 cells, 
immunoprecipitated and incubated in vitro in the presence or absence of recombinant PAK1. Shown are Western 
blots to document protein levels in the kinase assay (top and middle panels) and the corresponding autoradiograph 
showing phosphorylation of GFP-BCL-6 by PAK1 as well as PAK1 autophosphorylation (bottom panel). 
PAK1 acts downstream of Rac1 in the release of transcriptional repression 
by BCL-6. 
Screening for Rac1 effectors mediating 
the modulation  of BCL-6 activity 
DLD-1 cells were co-transfected with the transcriptional 
luciferase reporter vector under the control of five 
consensus BCL-6 binding motifs (see below) and the 
indicated constructs, corresponding to the active forms of 
various known Rac1 effector proteins. Note that  besides 
Rac1-L61 only expression of constitutively active PAK1 
releases BCL-6 repression, increasing Luciferase expression. 
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